Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease

NCT04429867 is registered in ClinicalTrials.gov with WellStar Health System as lead sponsor.

NCT NCT04429867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04429867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease
Lead sponsor
WellStar Health System
Phase
Phase 4
Overall status
Unknown status
Start date
May 7, 2020
Completion date
December 7, 2020
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19